Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9413 | FAM189A2 | AEH-subject3 | Human | Endometrium | AEH | 1.80e-17 | 5.17e-01 | -0.2576 |
9413 | FAM189A2 | AEH-subject5 | Human | Endometrium | AEH | 2.38e-04 | 2.79e-01 | -0.2953 |
9413 | FAM189A2 | EEC-subject1 | Human | Endometrium | EEC | 6.71e-05 | 2.77e-01 | -0.2682 |
9413 | FAM189A2 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 3.38e-02 | -1.55e-01 | -0.1883 |
9413 | FAM189A2 | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 1.65e-11 | 3.95e-01 | -0.1934 |
9413 | FAM189A2 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 3.29e-02 | -1.55e-01 | -0.1917 |
9413 | FAM189A2 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 1.03e-03 | -1.55e-01 | -0.1916 |
9413 | FAM189A2 | GSM5252132_BPH389PrGF | Human | Prostate | BPH | 7.11e-05 | 3.05e-01 | -0.2247 |
9413 | FAM189A2 | GSM5252136_BPH556PrGA1_Fcol | Human | Prostate | BPH | 6.98e-04 | 1.56e-01 | -0.23 |
9413 | FAM189A2 | GSM5252137_BPH556PrGA2_Fcol | Human | Prostate | BPH | 2.10e-05 | 3.02e-01 | -0.23 |
9413 | FAM189A2 | 048752_1579-all-cells | Human | Prostate | BPH | 8.71e-08 | 3.18e-01 | 0.1008 |
9413 | FAM189A2 | 052095_1628-all-cells | Human | Prostate | BPH | 3.09e-06 | 2.18e-01 | 0.1032 |
9413 | FAM189A2 | 052097_1595-all-cells | Human | Prostate | BPH | 6.41e-04 | 1.77e-01 | 0.0972 |
9413 | FAM189A2 | 052099_1652-all-cells | Human | Prostate | BPH | 1.65e-16 | 3.91e-01 | 0.1038 |
9413 | FAM189A2 | GSM5353222_PA_PB2B_Pool_1_3_S52_L002 | Human | Prostate | Tumor | 4.13e-05 | 3.77e-01 | 0.1608 |
9413 | FAM189A2 | GSM5353223_PA_PB2B_Pool_2_S26_L001 | Human | Prostate | Tumor | 5.45e-09 | 5.21e-01 | 0.1604 |
9413 | FAM189A2 | GSM5353224_PA_PR5186_Pool_1_2_3_S27_L001 | Human | Prostate | Tumor | 9.10e-11 | 5.94e-01 | 0.1621 |
9413 | FAM189A2 | GSM5353227_PA_PR5199-193K_Pool_1_2_3_S55_L002 | Human | Prostate | Tumor | 1.03e-03 | 3.84e-01 | 0.1602 |
9413 | FAM189A2 | GSM5353236_PA_PR5251_T1_S7_L001 | Human | Prostate | Tumor | 3.44e-03 | 5.56e-01 | 0.1608 |
9413 | FAM189A2 | GSM5353237_PA_PR5251_T2_S8_L001 | Human | Prostate | Tumor | 2.16e-04 | 5.84e-01 | 0.1622 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FAM189A2 | SNV | Missense_Mutation | novel | c.1015N>A | p.Ala339Thr | p.A339T | Q15884 | protein_coding | deleterious(0.04) | probably_damaging(0.941) | TCGA-D1-A2G5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
FAM189A2 | SNV | Missense_Mutation | novel | c.1309N>T | p.Arg437Trp | p.R437W | Q15884 | protein_coding | tolerated(0.11) | probably_damaging(0.999) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | rs149502376 | c.535N>A | p.Gly179Arg | p.G179R | Q15884 | protein_coding | tolerated(0.07) | probably_damaging(0.999) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | novel | c.1074N>C | p.Glu358Asp | p.E358D | Q15884 | protein_coding | tolerated(0.12) | benign(0.241) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | novel | c.317N>T | p.Ala106Val | p.A106V | Q15884 | protein_coding | deleterious(0.03) | probably_damaging(0.999) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | | c.968N>A | p.Arg323Gln | p.R323Q | Q15884 | protein_coding | tolerated(1) | benign(0.003) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | novel | c.47T>C | p.Val16Ala | p.V16A | Q15884 | protein_coding | deleterious(0) | benign(0.371) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | novel | c.884N>T | p.Ala295Val | p.A295V | Q15884 | protein_coding | deleterious(0) | probably_damaging(0.941) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | novel | c.1330N>A | p.Val444Ile | p.V444I | Q15884 | protein_coding | tolerated(0.15) | probably_damaging(0.987) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
FAM189A2 | SNV | Missense_Mutation | rs770184667 | c.1202N>A | p.Arg401Gln | p.R401Q | Q15884 | protein_coding | deleterious(0.02) | probably_damaging(0.994) | TCGA-EY-A1GQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | taxol | SD |